Aldershot, United Kingdom

Jeffrey Hammond

This inventor holds 1 USPTO granted patent. Top assignee: Commonwealth Scientific and Industrial Research Organisation. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey Hammond. Retrieved from https://idiyas.com/inventor/jeffrey-hammond-lusdlh26

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jeffrey Hammond

Introduction

Jeffrey Hammond is a notable inventor based in Aldershot, GB. He has made significant contributions to the field of biotechnology, particularly in the development of adenoviral vectors. His work focuses on enhancing the effectiveness of these vectors for therapeutic applications.

Latest Patents

Hammond holds a patent titled "Methods and compositions for increasing tissue tropism of recombinant adenoviral vectors." This patent outlines methods that allow for the preparation of adenoviral vectors with altered tropism. The compositions comprising such vectors and methods of use are also detailed in the patent. He has 1 patent to his name.

Career Highlights

Jeffrey Hammond is affiliated with the Commonwealth Scientific and Industrial Research Organisation, where he applies his expertise in biotechnology. His work has been instrumental in advancing the understanding and application of adenoviral vectors in medical research.

Collaborations

Hammond collaborates with various professionals in his field, including his coworker Michael A Johnson. Their combined efforts contribute to the innovative research being conducted at their organization.

Conclusion

Jeffrey Hammond's contributions to biotechnology, particularly through his patent on adenoviral vectors, highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…